API Tepoxalin
Dual-Action NSAID for Canine Pain and Inflammation Management
Product Introduction
Tepoxalin is a non-steroidal anti-inflammatory drug (NSAID) developed specifically for canine use to control pain and inflammation. Its dual mechanism of action targets two critical inflammatory pathways, providing enhanced relief and improved mobility in dogs affected by acute or chronic inflammatory conditions.
Category: Veterinary NSAID / Anti-Inflammatory API
Target Species: Dogs
Dosage Form: Oral Tablets
Mechanism of Action
Tepoxalin exerts its therapeutic effect by acting on two major enzymatic pathways involved in inflammation:
1. Cyclooxygenase (COX) Inhibition:
Reduces prostaglandin synthesis responsible for pain, swelling, and inflammatory response.
2. 5-Lipoxygenase (5-LOX) Inhibition:
Suppresses leukotriene production, contributing to broader inflammatory control, particularly in chronic cases.
This dual-pathway inhibition offers a wider anti-inflammatory effect compared to traditional NSAIDs that target only the COX pathway.
Veterinary Applications
Canine Osteoarthritis:
Relieves joint pain and stiffness while improving mobility and daily activity levels.
Post-Operative Pain Management:
Controls inflammation and discomfort following surgical procedures, supporting recovery.
Soft Tissue Injuries:
Reduces swelling and pain associated with sprains, strains, and acute injuries.
Dosage and Administration
Tepoxalin is administered orally in tablet form . The appropriate dosage depends on:
▸ Body weight of the dog
▸ Severity and type of inflammatory condition
▸ Duration of treatment protocol
Always administer under veterinary supervision.
Safety & Tolerability
When used according to professional guidance, Tepoxalin is generally well tolerated. Possible adverse reactions may include:
▸ Gastrointestinal irritation
▸ Alterations in liver or kidney parameters
Routine monitoring is recommended for long-term therapy.
Key Benefits
▸ Dual COX and 5-LOX inhibition
▸ Effective in both acute and chronic conditions
▸ Improves comfort and mobility
▸ Enhances overall quality of life in dogs
Conclusion
API Tepoxalin offers comprehensive inflammatory control through its dual-action mechanism, making it a valuable option for canine pain management. When administered responsibly under veterinary supervision, it significantly enhances mobility, comfort, and recovery outcomes in dogs.
Hot Tags: tepoxalin, China tepoxalin manufacturers, suppliers, factory, veterinary small molecular compounds for new drug development, Altrenogest CAS 850 52 2, small molecule compounds in veterinary drug discovery, small molecular chemicals for veterinary drug discovery, Maropitant CAS 147116 67 4, Pradofloxacin CAS 195532 12 8
